Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPP-4 Inhibitors Effects on Platelet Function in T2D Patients with AMI
NCT02377388Phase 3Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin, saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Feb 2017; status: completed.
02
Drugs
sitagliptinsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02377388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377388.